Hepatitis C infection in renal transplant patients: New insights and unanswered questions

Nephrology Dialysis Transplantation

Volumn 11, Issue SUPPL. 4, 1996, Pages 42-45

  Pirson, Yves ^a   Goffin, Eric ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

STEROID;

DISEASE COURSE; GENOTYPE; GRAFT REJECTION; HEMODIALYSIS; HEPATITIS C; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MUTAGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK; SHORT SURVEY; SURVIVAL; VIRUS REPLICATION;

EID: 0029859999     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/11.supp4.42     Document Type: Short Survey

References (23)

1. Goffin E, Pirson Y, Cornu C, Geubel A, Squifflet JP, Van Ypersele de Strihou C. Outcome of HCV infection after renal transplantation. Kidney Int 1994; 45: 551-555
2. Jadoul M, Cornu C, Van Yperselle De Strihouu C, group Uc. Incidence and risk factors for hepatitis C seroconversion in hemodialysis: a prospective study. Kidney Int 1993; 44: 1322-1326
3. Pereira BJG, Wright TL, Schmid CH, Levey AS. A controlled study of hepatitis C transmission by organ transplantation. Lancet 1995; 345: 484-487
4. Rot D, Fernandez JA, Babishkin S, De Mattos A, Buck BE, Quan S, Olson L, Burke W, Nery JR, Esquenazi V, Schiff ER, Miler J. Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease. Ann Int Med 1992; 117:470-475
5. Tesi RJ, Waller K, Morgan CJ, Delaney S, Elkhammas EA, Henry ML, Ferguson RM. Transmission of hepatitis C by kidney transplantation - the risks. Transplantation 1994; 57: 826-831
6. Vincenti F, Lake J, Wright T, Kuo G, Weber P, Stempel C. Nontransmission of hepatitis C from cadaver kidney donors to transplant recipients. Transplantation 1993; 55: 674-675
7. Pereira BJG, Milford EL, Kirkman RL, Quan S, Sayre KR, Johnson PJ, Wilber JC, Levey AS. Prevalence of hepatitis C virus RNA in organ donors positive for hepatitis C antibody and in the recipients of their organs. N Engl J Med 1992; 327: 910-915
8. Zucker K, Cirocco R, Roth D, Olson L, Burke GW, Nery J, Esquenazi V, Miller J. Depletion of hepatitis C virus from procured kidneys using pulsatile perfusion preservation. Transplantation 1994; 57: 832-840
9. Kiberd BA. Should hepatitis C-infected kidneys be transplanted in the United States? Transplantation 1994; 57: 1068-1072
10. Morales JM, Campistol JM, Castellano G, Andres A, Colina F, Fuertes A, Ercilla G, Bruguera M, Andren J, Carretero P, Rodicio JL, Levey AS, Pereira BJG. Transplantation 1994; 57: 1068-1072
11. Widell A, Mansson S, Persson NH, Thysell H, Hermodsson S, Blohme I. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney. Transplantation 1995; 60: 642-647
12. Chan TM, Lok ASF, Cheng IKP, Chan RT. A prospective study of hepatitis C virus infection among renal transplant recipients. Gastroenterology 1993; 104: 862-868
13. Lau JYN, Davis GL, Brunson ME, Qian KP, Lin HJ, Quan S, DiNello R, Polito AJ, Scornik JC. Hepatitis C virus infection in kidney transplant recipients, Hepatology 1993; 18: 1027-1031
14. Goffin E, Pirson Y, Cornu C, Jadoul M, Van Ypersele de Strihou C. Significance of NS3 and NS5 antigens in screening for HCV antibody. Lancet 1994: 343-354
15. Fong TL, Valinluck B, Govindarajan S, Charboneau F, Adkins RH, Redeker AG. Short-term prednisone therapy affects amino-transferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196-199
16. Pol S, Legendre C, Saltiel C, Carnot F, Bréchot C, Berthelot P, Mattlinger B, Kreis H. Hepatitis C virus in kidney recipients: epidemiology and impact on renal transplantation. J Hepatol 1992; 15: 202-206
17. Orloff SL, Stempel CA, Wright TL, Tomlanovich SJ, Amend WJC, Stock PG, Melzer JS, Vincenti F. Long-term outcome in kidney transplant patients with hepatitis C (HCV) infection. Clin Transplantation 1995; 9: 119-124
18. Ynares C, Johson HK, Kerlin T, Crowe D, MacDonell R, Richie R. Impact of pretransplant hepatitis C antibody status upon long-term patient and renal allograft survival - a 5- and 10-year follow-up. Transplant Proc 1993; 25: 1466-1468
19. Roth D, Zucker K, Cirocco R, De Mattos A, Burke GW, Nery J, Esquenazi V, Babischkin S, Miller J. The impact of hepatitis C virus infection on renal allograft recipients. Kidney Int 1994; 45: 238-244
20. Pereira BJG, Wright TL, Schmid CH, Levey AS. The impact of pretransplantation hepatitis C infection on the outcome of renal transplantations. Transplantation 1995; 60: 799-805
21. Goffin E, Pirson Y, Van Ypersele de Strihou C. Implications of HBV or HCV infection for renal transplant candidates. Nephrol Dial Transplant 1995, in press
22. Report of a meeting of Physicians and Scientists, Royal Free Hospital and School of Medicine, London. Genetic diversity of hepatitis C virus: implications for pathogenesis, treatment and prevention. Lancet 1995; 345: 562-566
23. Horina JH, Wirnsberger GH, Kenner L, Holzer H, Krejs GJ. Increased susceptibility for CsA-induced hepatotoxicity in kidney graft recipients with chronic viral hepatitis C. Transplantation 1993; 56: 1091-1094